Free Trial

AXIM Biotechnologies (AXIM) SEC Filings & 10K Form

$0.0090
0.00 (0.00%)
(As of 05/28/2024 ET)

Recent AXIM Biotechnologies SEC Filings

DateFilerForm TypeView
05/20/2024
3:24 PM
AXIM Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2024
4:25 PM
AXIM Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
1:55 PM
AXIM Biotechnologies (Filer)
Form NT 10-K
03/21/2024
2:47 PM
AXIM Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
6:59 PM
AXIM Biotechnologies (Issuer)
HUEMOELLER JOHN WALTER II (Reporting)
Form 4/A
03/19/2024
6:29 PM
AXIM Biotechnologies (Issuer)
Scott Timothy Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:33 PM
AXIM Biotechnologies (Issuer)
Cunningham Robert L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:37 PM
AXIM Biotechnologies (Issuer)
Schroeder Blake (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:39 PM
AXIM Biotechnologies (Issuer)
Valencia Catalina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:14 PM
AXIM Biotechnologies (Issuer)
HUEMOELLER JOHN WALTER II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:16 PM
AXIM Biotechnologies (Issuer)
MALASEK ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:24 PM
AXIM Biotechnologies (Issuer)
O'Rourke Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
10:59 AM
AXIM Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
3:29 PM
AXIM Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/21/2023
10:07 AM
AXIM Biotechnologies (Filer)
Form DEF 14C
08/21/2023
12:35 PM
AXIM Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/11/2023
11:15 PM
AXIM Biotechnologies (Filer)
Form EFFECT
06/02/2023
1:51 PM
AXIM Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
1:19 PM
AXIM Biotechnologies (Issuer)
Phinney Kurt (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (OTCMKTS:AXIM) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners